Muskelin inhibitors encompass a diverse range of chemicals that can indirectly affect the functions of Muskelin, particularly given its non-enzymatic nature. These inhibitors target various aspects of cellular functioning, including proteasomal degradation, endosomal processes, cytoskeletal dynamics, and cell signaling pathways. Firstly, proteasome inhibitors like MG-132 [Z-Leu- Leu-Leu-CHO] are crucial as Muskelin is involved in ubiquitination and subsequent proteasomal degradation of certain proteins. By inhibiting the proteasome, these chemicals can indirectly affect Muskelin's role in protein degradation. Similarly, Bafilomycin A1's role in disrupting endosomal acidification can impede Muskelin's function in receptor internalization and degradation, notably affecting GABRA1 dynamics. On the cytoskeletal front, chemicals such as Jasplakinolide, Y-27632, free base, and CK 666 play significant roles. Jasplakinolide stabilizes actin filaments, potentially counteracting Muskelin's mediating effects on the cytoskeleton. Y-27632, free base and CK 666, by inhibiting ROCK and the Arp2/3 complex respectively, can also modulate Muskelin's influence on cell spreading and cytoskeletal organization. This aspect is critical since Muskelin acts as a mediator in cytoskeletal responses to external stimuli.
Furthermore, Muskelin's functionality is likely intertwined with various signaling pathways. Inhibitors like Thapsigargin, Wortmannin, U0126, PD 98059, and LY 294002 provide insight into how disruption of calcium homeostasis, PI3K/Akt, and MAPK/ERK signaling pathways might influence Muskelin's activity. By modulating these pathways, these chemicals offer a window into understanding how signaling alterations can indirectly impact Muskelin's roles in the cell. In conclusion, the diverse array of Muskelin inhibitors, primarily functioning through indirect mechanisms, highlights the complex interplay between Muskelin and various cellular processes. These inhibitors, by targeting proteasomal degradation, endosomal functions, cytoskeletal dynamics, and cell signaling pathways, provide valuable tools for dissecting Muskelin's role in cellular physiology and pathophysiology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A potent, reversible, and cell-permeable proteasome inhibitor. It inhibits the degradation of ubiquitinated proteins, thus indirectly affecting Muskelin-mediated proteasomal degradation pathways. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
A specific inhibitor of vacuolar H+-ATPases. It disrupts endosomal acidification, indirectly affecting Muskelin-mediated internalization and degradation of receptors like GABRA1. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments and inhibits actin dynamics. It can indirectly influence Muskelin-mediated cytoskeletal responses. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A selective inhibitor of ROCK (Rho-associated protein kinase), potentially affecting Muskelin's role in cell spreading and cytoskeletal organization. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), it disrupts calcium homeostasis, potentially influencing Muskelin-related pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent inhibitor of phosphatidylinositol 3-kinase (PI3K), which may indirectly influence Muskelin-mediated processes through PI3K/Akt signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor, further impacting the MAPK/ERK signaling pathway and potentially Muskelin's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, similar to Wortmannin, providing an alternative for studying Muskelin-related PI3K/Akt pathways. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
An Arp2/3 complex inhibitor, affecting actin polymerization and thus potentially influencing Muskelin's role in cytoskeletal reorganization. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
An inhibitor of myosin II ATPase activity, affecting muscle contraction and cellular motility, potentially impacting Muskelin's cellular functions. | ||||||